| Institution: | RACHEL LEHENY, PhD, and ERIC ROBERTS are co‐founders of Valence Life Sciences and Caxton Advantage Life Sciences, late‐stage venture funds. Before becoming venture capitalists, they worked together at Lehman Brothers where they lead the life sciences banking (Eric) and research (Rachel) teams. Prior to that, they ran the life sciences efforts at UBS. Rachel started her carreer at Hambrecht & Quist, and Eric started his at Dillon Read. Rachel holds at doctorate in chemistry from Columbia University and a AB in chemistry from Harvard University, and Eric holds a BS from the Wharton School of Business. |
